Abstract
The aim of this prospective study was to evaluate the diagnostic utility of a technetium-99m sestamibi dual-phase protocol enhanced by single-photon emission tomography (SPET) and semiquantitative analysis in comparison to established preoperative staging procedures in patients with primary hyperparathyroidism. Twenty-eight (50%) out of 56 patients had superimposed thyroid disease, and 12 patients had previously undergone neck surgery. Visual and semiquantitative analysis of planar99mTc-sestamibi dual-phase imaging, SPET of the delayed phase, ultrasonography, and thallium-201 chloride-technetium-99m pertechnetate subtraction scintigraphy was further correlated with the histopathological examination of the surgical specimens.99mTc-sestamibi dual-phase imaging achieved the highest sensitivity for side localization and precise localization compared with201Tl-99mTc subtraction scintigraphy and ultrasonography, but the differences reached statistical significance only in comparison to ultrasonography. Semiquantitative analysis did not enhance sensitivity. Adenoma detection by99mTc-sestamibi dual-phase imaging was only correlated to serum calcium levels and osteocalcin, not to cell density or oxyphil cell count (SPET yielded additional information for the exact topographical localization of the parathyroid tumour in 22 (39%) patients with superimposed thyroid disease or previous neck surgery but did not enhance the overall detection rate.
Similar content being viewed by others
References
Niederle B, Roka R, Fritsch A. Long-term results after surgical treatment of primary hyperparathyroidism.Prog Surg 1986; 18: 146–164.
Casas AT, Burke GJ, Mansberger AR, Wie JP. Impact of technetium-99m-sestamibi localization on operative time and success of operations for primary hyperparathyroidism.Am Surg 1994, 60: 12–16.
Wie JP, Burke GJ. Analysis of savings in operative time for primary hyperparathyroidism using localization with technetium 99m sestamibi scan.Am J Surg 1995; 170: 488–491.
Fukunaga M, Morita R, Yonekura Y, et al. Accumulation of201Tl-chloride in a parathyroid adenoma.Clin Nucl Med 1979; 4: 229–230.
Ferlin G, Bursato N, Camerani M, Conte N, Zotti D. New perspectives in localizing enlarged parathyroid glands by technetium-thallium subtraction scan.J Nucl Med 1983; 24: 438–441.
Young AE, Gaunt JI, Groft DN, Collins REC, Wells CP, Coakley AJ. Location of parathyroid adenomas by thallium-201 and technetium-99m subtraction scanning.Br Med J 1983; 286: 1384–1386.
Hauty M, Swatz K, McClung M et al. Technetium-thallium scintiscanning for the localization of parathyroid adenomas and hyperplasia; a reappraisal.Am J Surg 1987; 153: 479–486.
Taillefer R, Boucher Y, Potvin C, Lambert R. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double-phase study).J Nucl Med 1992; 33: 1801–1807.
Johnston LB, Carroll MJ, Britton KE, Lowe DG, Shand W, Besser GM, Grossman AB. The accuracy of parathyroid gland localization in primary hyperparathyroidism using sestamibi radionuclide imaging.J Clin Endocrinol Metab 1996; 81: 346–352.
Jones AG, Abrams MJ, Davison A, Brodack JW, Toothaker AK, Adelstein SJ, Kassis AI. Biological studies of a new class of technetium complexes: the hexakis(alkylisonitrile)technetium(I) cations.Int J Nucl Med Biol 1984; 11: 225–234.
Kronauge JF, Chiu ML, Cone JS, Davison A, Holman BL, Jones AG, Piwnica-Worms D. Comparison of neutral and cationic myocardial perfusion agents, characteristics of accumulation in cultured cells.Nucl Med Biol 1992; 19: 141–148.
Chernoff DM, Strichartz GR, Piwnica-Worms D. Membrane potential determination in large unilamellar vesicles with hexakis(2-methoxyisobutylisonitrile)technetium(I).Biochem Biophys Acta 1993; 1147: 262–266.
Chiu ML, Kronange JF, Piwnica-Worms D. Effect of mitochondrial and plasma-membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium in cultured mouse fibroblasts.J Nucl Med 1990; 31: 1646–1653.
Sandrock D, Merino MJ, Norton JA, Neumann RD. Ultrastructural histology correlates with results of thallium-201/technetium-99m parathyroid subtraction scintigraphy.J Nucl Med 1993; 34: 24–29.
Bénard F, Lefebvre B, Beuvon F, Langlois MF, Bisson G. Rapid washout of technetium-99m-MIBI from a large parathyroid adenomal.J Nucl Med 1995; 36: 241–243.
Altenähr E. The parathyroid glands. In: Johannessen JV, ed.Ele tron microscopy in human medicine, vol 10. New York: McGraw-Hill; 1981: 111–146.
Weibl E.Stereological methods I and II. London: Academic press, 1979.
Okerlund MD, Sheldon K, Corpus S, et al. A new method with high sensitivity and specificity for localization for abnormal parathyroid glands.Ann Surg 1984; 200: 381–388.
Basarab RM, Manni A, Harrison TS. Dual isotope subtraction parathyroid scintigraphy in the preoperative evaluation of suspect hyperparathyroidism.Clin Nucl Med 1985; 10: 300–314.
Sandrock D, Merino MJ, Norton JA, Neumann RD. Parathyroid imaging by Tc/Tl scintigraphy.Eur J Nucl Med 1990; 16: 607–613.
Coakley AJ. Parathyroid imaging.Nucl Med Commun 1995; 16: 522–533.
McBiles M, Lambert AT, Cote MG, Kim SY. Sestamibi parathyroid imaging.Semin Nucl Med 1995; 25: 221–234.
Staudenherz A, Telfeyan D, Steiner E, Niederle B, Leitha T, Kletter K. Scintigraphic pitfall in giant parathyroid glands.J Nucl Med 1995; 36: 467–469.
Chan TYK, Serpell JW, Chan O, Gaunt JI, Young AE, Nunan TO. Misinterpretation of the upper parathyroid adenoma on thallium-201/technetium-99m subtraction scintigraphy.Br J Radiol 1991 64: 1–4.
Caixas A, Berna L, Piera J, Rigla M, Matias-Guiu X, Farrerons J, Puig-Domingo M. Utility of99mTc-sestamibi scintigraphy as a first-line imaging procedure in the evaluation of hyperparathyroidism.Clin Endocrinol (Oxf) 1995; 43: 523–524.
Földes I, Levay A, Stotz G. Comparative scanning of thyroid nodules with technetium-99m pertechnetate and technetium-99m methoxyisobutylisonitrile.Eur J Nucl Med 1993; 20: 330–333.
Billotey C, Aurengo A, Najean Y, et al. Identifying abnormal parathyroid glands in the thyroid uptake area using technetium-99m-sestamibi and factor analysis of dynamic structures.J Nucl Med 1994; 35: 1631–1636.
Caravalho J, Balingit AG, Rivera-Rodriguez JE, et al. Localization of an ectopic parathyroid adenoma by double phase technetium-99m-sestamibi scintigraphy.J Nucl Med 1995; 36: 1840–1842.
Schoenemann B, Wurm K, Bihl H, Merkle P. The importance of99mTc-MIBI scintigraphy in localization of abnormal parathyroid glands in hyperparathyroidism. A prospective study.Chirurg 1996; 67: 32–36.
Juhlin C, Klareshog C, Nygren P, et al. Hyperparathyroidism is associated with reduced expression of a parathyroid calcium receptor mechanism defined by monoclonal antiparathyroid antibodies.Endocrinology 1988; 122: 2999–3001.
Doppman JL. Reoperative parathyroid surgery: localization procedure. Parathyroid surgery.Prog Surg 1986; 18: 117–132.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Staudenherz, A., Abela, C., Niederle, B. et al. Comparison and histopathological correlation of three parathyroid imaging methods in a population with a high prevalence of concomitant thyroid diseases. Eur J Nucl Med 24, 143–149 (1997). https://doi.org/10.1007/BF02439546
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02439546